You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2+ T cells activities after hematopoietic transplantation for blood malignancies

Citation Tools

Article menu

Download PDFPDF

XML
Immune cell therapies and immune cell engineering
Original research
Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2+ T cells activities after hematopoietic transplantation for blood malignancies

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Liu J, Gao H, Xu L, et al
Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2+ T cells activities after hematopoietic transplantation for blood malignancies
Journal for ImmunoTherapy of Cancer 2020;8:e000208. doi: 10.1136/jitc-2019-000208